4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001197350-26-000002
CHIEF FINANCIAL OFFICER sold 1,053 shares at $96.19 ($101,290)
- CHIEF FINANCIAL OFFICER acquired 2,667 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | 2026-01-23 | Option exercise | +2,667 | 44,794 | D | ||
| BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | 2026-01-26 | Sale | −1,053 | $96.19 | $101,290 | 43,741 | D |
| Derivatives | |||||||
| BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | 2026-01-23 | Option exercise · Restricted Stock Units | −2,667 | 2,666 | D | ||
| Open-market sales · 1,053 sh · avg $96.19 · $101,290 | |||||||
Loading xslF345X05/form4-01272026_040108.xml…